Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder

被引:91
|
作者
Severance E.G. [1 ]
Gressitt K.L. [1 ]
Stallings C.R. [2 ]
Katsafanas E. [2 ]
Schweinfurth L.A. [2 ]
Savage C.L. [2 ]
Adamos M.B. [2 ]
Sweeney K.M. [2 ]
Origoni A.E. [2 ]
Khushalani S. [2 ]
Leweke F.M. [3 ]
Dickerson F.B. [2 ]
Yolken R.H. [1 ]
机构
[1] Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD
[2] Sheppard Pratt Health System, Stanley Research Program, Baltimore, MD
[3] Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim
来源
npj Schizophrenia | / 2卷 / 1期
关键词
D O I
10.1038/npjschz.2016.18
中图分类号
学科分类号
摘要
Immune aberrations in schizophrenia and bipolar disorder have led to the hypotheses that infectious agents or corresponding immune responses might contribute to psychiatric etiopathogeneses. We investigated case-control differences in exposure to the opportunistic fungal pathogen, Candida albicans, and examined associations with cognition, medication, lifestyle, and somatic conditions. We quantified C. albicans IgG antibodies in two cohorts totaling 947 individuals and evaluated odds ratios (OR) of exposure with psychiatric disorder using multivariate regressions. The case-control cohort included 261 with schizophrenia, 270 with bipolar disorder, and 277 non-psychiatric controls; the second included 139 with first-episode schizophrenia, 78 of whom were antipsychotic naive. No differences in C. albicans exposures were found until diagnostic groups were stratified by sex. In males, C. albicans seropositivity conferred increased odds for a schizophrenia diagnosis (OR 2.04-9.53, P 1/20.0001). In females, C. albicans seropositivity conferred increased odds for lower cognitive scores on Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in schizophrenia (OR 1.12, P 1/20.004), with significant decreases on memory modules for both disorders (P 1/20.0007-0.03). C. albicans IgG levels were not impacted by antipsychotic medications. Gastrointestinal (GI) disturbances were associated with elevated C. albicans in males with schizophrenia and females with bipolar disorder (P 1/20.009-0.02). C. albicans exposure was associated with homelessness in bipolar males (P 1/20.0015). In conclusion, sex-specific C. albicans immune responses were evident in psychiatric disorder subsets. Inquiry regarding C. albicans infection or symptoms may expedite amelioration of this treatable comorbid condition. Yeast exposure as a risk factor for schizophrenia and its associated cognitive and GI effects require further investigation including the possible contribution of gut-brain mechanisms.
引用
收藏
相关论文
共 50 条
  • [31] Diagnostic Specificity of Neurophysiological Endophenotypes in Schizophrenia and Bipolar Disorder
    Johannesen, Jason K.
    O'Donnell, Brian F.
    Shekhar, Anantha
    McGrew, John H.
    Hetrick, William P.
    SCHIZOPHRENIA BULLETIN, 2013, 39 (06) : 1219 - 1229
  • [32] Comparing cognitive deficits in patient with soft bipolar disorder with those with bipolar I disorder
    Xu, G.
    Lu, W.
    Ouyang, H.
    Dang, Y.
    Guo, Y.
    Lin, K.
    BIPOLAR DISORDERS, 2014, 16 : 70 - 70
  • [33] Social cognitive endophenotypes in bipolar disorder and schizophrenia?
    Green, M. J.
    Sparks, A.
    Lino, B. J.
    McDonald, S.
    Mitchell, P. B.
    BIPOLAR DISORDERS, 2010, 12 : 23 - 23
  • [34] Differing cognitive profiles in bipolar disorder and schizophrenia
    Rebecca Ireland
    Nature Clinical Practice Neurology, 2006, 2 (6): : 292 - 292
  • [35] Cognitive enhancing agents in schizophrenia and bipolar disorder
    Vreeker, Annabel
    van Bergen, Annet H.
    Kahn, Rene S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (07) : 969 - 1002
  • [36] Cognitive control of gaze in bipolar disorder and schizophrenia
    Thakkar, Katharine N.
    Schall, Jeffrey D.
    Logan, Gordon D.
    Park, Sohee
    PSYCHIATRY RESEARCH, 2015, 225 (03) : 254 - 262
  • [37] GENETICS OF COGNITIVE FUNCTION IN SCHIZOPHRENIA AND BIPOLAR DISORDER
    Harvey, Philip
    Sun, Ning
    Lu, Qiongshi
    Hu, Yiming
    Li, Boyang
    Chen, Quan
    Aslan, Mihaela
    Radhakrishnan, Krishnan
    Cheung, Kei-Hoi
    Li, Yuli
    Sayward, Frederick
    Rajeevan, Nallakkandi
    Zhao, Hongyu
    Gaziano, Michael
    Concato, John
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S967 - S968
  • [38] Cognitive vulnerability indicators in bipolar disorder and schizophrenia
    Tessa Christodoulou
    Michael Hadjulis
    Jigar Jogia
    Sam J Gilbert
    Sophia Frangou
    Paul W Burgess
    Annals of General Psychiatry, 7 (Suppl 1)
  • [39] Adjudicating cognitive endophenotypes for bipolar disorder and schizophrenia
    Green, M. J.
    Lino, B. J.
    Sparks, A.
    Hyett, M.
    Mitchell, P. B.
    BIPOLAR DISORDERS, 2010, 12 : 23 - 23
  • [40] Subjective cognitive deficits in bipolar disorder: a Mexican study
    Yoldi, M.
    Martinez-Camarillo, S.
    Ortega-Ortiz, H.
    Castaneda-Franco, M.
    Becerra-Palars, C.
    BIPOLAR DISORDERS, 2018, 20 : 109 - 109